MedTrace Logo

Canadian CHO-KLAT/H-FIT Study - Quality of Life of, and Burden of Caring for, Persons With Hemophilia

NCT06191068 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 190

Last updated 2026-04-24

No results posted yet for this study

Summary

The primary goal of this observational study is to determine if:

* health-related quality of life of boys with moderate/severe hemophilia A who are followed in Canadian pediatric hemophilia treatment centres is significantly different for boys receiving an intravenously administered factor replacement product compared to a subcutaneously administered non-factor replacement product, as measured at the 3 month time-point.
* Burden of caring for a boy with moderate/severe hemophilia A is significantly different for parents/caregivers of boys with moderate/severe hemophilia A receiving an intravenously administered factor replacement product compared to a subcutaneously administered non-factor replacement product, as measured at the 3 month time-point.

Persons with hemophilia and their caregivers will complete questionnaires at baseline, three months, six months, and one week after six months.

Conditions

Sponsors & Collaborators

  • Roche Pharma AG

    collaborator INDUSTRY

  • The Hospital for Sick Children

    lead OTHER

Eligibility

Min Age
1 Month
Max Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-02
Primary Completion
2025-11-30
Completion
2025-11-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06191068 on ClinicalTrials.gov